Nektar Therapeutics (NKTR)
42.28
+0.38
(+0.91%)
USD |
NASDAQ |
Dec 31, 16:00
42.26
-0.02
(-0.06%)
After-Hours: 20:00
Nektar Therapeutics Total Liabilities (Quarterly): 216.26M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Insmed, Inc. | 1.415B |
| Lyell Immunopharma, Inc. | 78.84M |
| Owlet, Inc. | 113.46M |
| Amgen, Inc. | 80.52B |
| Rigel Pharmaceuticals, Inc. | 124.92M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 301.35M |
| Shareholders Equity (Quarterly) | 85.09M |
| Debt to Equity Ratio | 1.964 |
| Current Ratio | 4.241 |
| Net Debt Paydown Yield | 1.07% |